Global burden of disease due to rifampicin-resistant tuberculosis: a mathematical modeling analysis
Abstract In 2020, almost half a million individuals developed rifampicin-resistant click here tuberculosis (RR-TB).We estimated the global burden of RR-TB over the lifetime of affected individuals.We synthesized data on incidence, case detection, and treatment outcomes in 192 countries (99.99% of global tuberculosis).Using a mathematical model, we